+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tuberculosis Therapeutics - Market Analysis, Trends, and Forecasts

  • ID: 1227810
  • Report
  • 240 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Astrazeneca Plc
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Lupin Ltd.
  • Merck & Co., Inc.
  • MORE
The Tuberculosis Therapeutics market worldwide is projected to grow by US$376.1 Million, driven by a compounded growth of 4.9%. Active TB, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$810.1 Million by the year 2025, Active TB will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$13.2 Million to the region's size and clout in the next 5 to 6 years. Over US$10.7 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Active TB will reach a market size of US$43.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.9% over the next couple of years and add approximately US$110.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • AstraZeneca PLC
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Lupin Ltd.
  • Merck & Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Panacea Biotec Ltd.
  • Pfizer, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astrazeneca Plc
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Lupin Ltd.
  • Merck & Co., Inc.
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Tuberculosis Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Tuberculosis Therapeutics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 2: Tuberculosis Therapeutics Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017

TABLE 3: Tuberculosis Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Active TB (Disease Type) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 5: Active TB (Disease Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 6: Active TB (Disease Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Latent TB (Disease Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 8: Latent TB (Disease Type) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017

TABLE 9: Latent TB (Disease Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: First-Line Therapy (Therapy) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 11: First-Line Therapy (Therapy) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017

TABLE 12: First-Line Therapy (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Second-Line Therapy (Therapy) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025

TABLE 14: Second-Line Therapy (Therapy) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 15: Second-Line Therapy (Therapy) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Tuberculosis Therapeutics Market Share (in %) by Company: 2019 & 2025

TABLE 16: United States Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Disease Type: 2018 to 2025

TABLE 17: Tuberculosis Therapeutics Market in the United States by Disease Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 18: United States Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 19: United States Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Therapy: 2018 to 2025

TABLE 20: Tuberculosis Therapeutics Market in the United States by Therapy: A Historic Review in US$ Thousand for 2009-2017

TABLE 21: United States Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

CANADA

TABLE 22: Canadian Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025

TABLE 23: Canadian Tuberculosis Therapeutics Historic Market Review by Disease Type in US$ Thousand: 2009-2017

TABLE 24: Tuberculosis Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025

TABLE 25: Canadian Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018 to 2025

TABLE 26: Canadian Tuberculosis Therapeutics Historic Market Review by Therapy in US$ Thousand: 2009-2017

TABLE 27: Tuberculosis Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

JAPAN

TABLE 28: Japanese Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 29: Tuberculosis Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017

TABLE 30: Japanese Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025

TABLE 31: Japanese Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Therapy for the Period 2018-2025

TABLE 32: Tuberculosis Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Therapy for the Period 2009-2017

TABLE 33: Japanese Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

CHINA

TABLE 34: Chinese Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 35: Tuberculosis Therapeutics Historic Market Analysis in China in US$ Thousand by Disease Type: 2009-2017

TABLE 36: Chinese Tuberculosis Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 37: Chinese Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Therapy for the Period 2018-2025

TABLE 38: Tuberculosis Therapeutics Historic Market Analysis in China in US$ Thousand by Therapy: 2009-2017

TABLE 39: Chinese Tuberculosis Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Tuberculosis Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 40: European Tuberculosis Therapeutics Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025

TABLE 41: Tuberculosis Therapeutics Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017

TABLE 42: European Tuberculosis Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 43: European Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025

TABLE 44: Tuberculosis Therapeutics Market in Europe in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017

TABLE 45: European Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 46: European Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025

TABLE 47: Tuberculosis Therapeutics Market in Europe in US$ Thousand by Therapy: A Historic Review for the Period 2009-2017

TABLE 48: European Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

FRANCE

TABLE 49: Tuberculosis Therapeutics Market in France by Disease Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 50: French Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Disease Type: 2009-2017

TABLE 51: French Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025

TABLE 52: Tuberculosis Therapeutics Market in France by Therapy: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 53: French Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Therapy: 2009-2017

TABLE 54: French Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

GERMANY

TABLE 55: Tuberculosis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 56: German Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017

TABLE 57: German Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 58: Tuberculosis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025

TABLE 59: German Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017

TABLE 60: German Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

ITALY

TABLE 61: Italian Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 62: Tuberculosis Therapeutics Historic Market Analysis in Italy in US$ Thousand by Disease Type: 2009-2017

TABLE 63: Italian Tuberculosis Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 64: Italian Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Therapy for the Period 2018-2025

TABLE 65: Tuberculosis Therapeutics Historic Market Analysis in Italy in US$ Thousand by Therapy: 2009-2017

TABLE 66: Italian Tuberculosis Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 67: United Kingdom Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 68: Tuberculosis Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017

TABLE 69: United Kingdom Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025

TABLE 70: United Kingdom Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Therapy for the Period 2018-2025

TABLE 71: Tuberculosis Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Therapy for the Period 2009-2017

TABLE 72: United Kingdom Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

SPAIN

TABLE 73: Spanish Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025

TABLE 74: Spanish Tuberculosis Therapeutics Historic Market Review by Disease Type in US$ Thousand: 2009-2017

TABLE 75: Tuberculosis Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025

TABLE 76: Spanish Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018 to 2025

TABLE 77: Spanish Tuberculosis Therapeutics Historic Market Review by Therapy in US$ Thousand: 2009-2017

TABLE 78: Tuberculosis Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

RUSSIA

TABLE 79: Russian Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Disease Type: 2018 to 2025

TABLE 80: Tuberculosis Therapeutics Market in Russia by Disease Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 81: Russian Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 82: Russian Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Therapy: 2018 to 2025

TABLE 83: Tuberculosis Therapeutics Market in Russia by Therapy: A Historic Review in US$ Thousand for 2009-2017

TABLE 84: Russian Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 85: Rest of Europe Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025

TABLE 86: Tuberculosis Therapeutics Market in Rest of Europe in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017

TABLE 87: Rest of Europe Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 88: Rest of Europe Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025

TABLE 89: Tuberculosis Therapeutics Market in Rest of Europe in US$ Thousand by Therapy: A Historic Review for the Period 2009-2017

TABLE 90: Rest of Europe Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 91: Asia-Pacific Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 92: Tuberculosis Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017

TABLE 93: Asia-Pacific Tuberculosis Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 94: Tuberculosis Therapeutics Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 95: Asia-Pacific Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Disease Type: 2009-2017

TABLE 96: Asia-Pacific Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025

TABLE 97: Tuberculosis Therapeutics Market in Asia-Pacific by Therapy: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 98: Asia-Pacific Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Therapy: 2009-2017

TABLE 99: Asia-Pacific Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 100: Tuberculosis Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 101: Australian Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017

TABLE 102: Australian Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 103: Tuberculosis Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025

TABLE 104: Australian Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017

TABLE 105: Australian Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

INDIA

TABLE 106: Indian Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025

TABLE 107: Indian Tuberculosis Therapeutics Historic Market Review by Disease Type in US$ Thousand: 2009-2017

TABLE 108: Tuberculosis Therapeutics Market in India: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025

TABLE 109: Indian Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018 to 2025

TABLE 110: Indian Tuberculosis Therapeutics Historic Market Review by Therapy in US$ Thousand: 2009-2017

TABLE 111: Tuberculosis Therapeutics Market in India: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

SOUTH KOREA

TABLE 112: Tuberculosis Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 113: South Korean Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017

TABLE 114: Tuberculosis Therapeutics Market Share Distribution in South Korea by Disease Type: 2009 VS 2019 VS 2025

TABLE 115: Tuberculosis Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025

TABLE 116: South Korean Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017

TABLE 117: Tuberculosis Therapeutics Market Share Distribution in South Korea by Therapy: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 118: Rest of Asia-Pacific Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 119: Tuberculosis Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017

TABLE 120: Rest of Asia-Pacific Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025

TABLE 121: Rest of Asia-Pacific Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Therapy for the Period 2018-2025

TABLE 122: Tuberculosis Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Therapy for the Period 2009-2017

TABLE 123: Rest of Asia-Pacific Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 124: Latin American Tuberculosis Therapeutics Market Trends by Region/Country in US$ Thousand: 2018-2025

TABLE 125: Tuberculosis Therapeutics Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 126: Latin American Tuberculosis Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 127: Latin American Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 128: Tuberculosis Therapeutics Historic Market Analysis in Latin America in US$ Thousand by Disease Type: 2009-2017

TABLE 129: Latin American Tuberculosis Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 130: Latin American Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Therapy for the Period 2018-2025

TABLE 131: Tuberculosis Therapeutics Historic Market Analysis in Latin America in US$ Thousand by Therapy: 2009-2017

TABLE 132: Latin American Tuberculosis Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 133: Argentinean Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025

TABLE 134: Tuberculosis Therapeutics Market in Argentina in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017

TABLE 135: Argentinean Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 136: Argentinean Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025

TABLE 137: Tuberculosis Therapeutics Market in Argentina in US$ Thousand by Therapy: A Historic Review for the Period 2009-2017

TABLE 138: Argentinean Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

BRAZIL

TABLE 139: Tuberculosis Therapeutics Market in Brazil by Disease Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 140: Brazilian Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Disease Type: 2009-2017

TABLE 141: Brazilian Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025

TABLE 142: Tuberculosis Therapeutics Market in Brazil by Therapy: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 143: Brazilian Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Therapy: 2009-2017

TABLE 144: Brazilian Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

MEXICO

TABLE 145: Tuberculosis Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 146: Mexican Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017

TABLE 147: Mexican Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 148: Tuberculosis Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025

TABLE 149: Mexican Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017

TABLE 150: Mexican Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 151: Rest of Latin America Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Disease Type: 2018 to 2025

TABLE 152: Tuberculosis Therapeutics Market in Rest of Latin America by Disease Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 153: Rest of Latin America Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 154: Rest of Latin America Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Therapy: 2018 to 2025

TABLE 155: Tuberculosis Therapeutics Market in Rest of Latin America by Therapy: A Historic Review in US$ Thousand for 2009-2017

TABLE 156: Rest of Latin America Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 157: The Middle East Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 158: Tuberculosis Therapeutics Market in the Middle East by Region/Country in US$ Thousand: 2009-2017

TABLE 159: The Middle East Tuberculosis Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 160: The Middle East Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025

TABLE 161: The Middle East Tuberculosis Therapeutics Historic Market by Disease Type in US$ Thousand: 2009-2017

TABLE 162: Tuberculosis Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025

TABLE 163: The Middle East Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018 to 2025

TABLE 164: The Middle East Tuberculosis Therapeutics Historic Market by Therapy in US$ Thousand: 2009-2017

TABLE 165: Tuberculosis Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

IRAN

TABLE 166: Iranian Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 167: Tuberculosis Therapeutics Market in Iran: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017

TABLE 168: Iranian Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025

TABLE 169: Iranian Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Therapy for the Period 2018-2025

TABLE 170: Tuberculosis Therapeutics Market in Iran: Historic Sales Analysis in US$ Thousand by Therapy for the Period 2009-2017

TABLE 171: Iranian Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

ISRAEL

TABLE 172: Israeli Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025

TABLE 173: Tuberculosis Therapeutics Market in Israel in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017

TABLE 174: Israeli Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 175: Israeli Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025

TABLE 176: Tuberculosis Therapeutics Market in Israel in US$ Thousand by Therapy: A Historic Review for the Period 2009-2017

TABLE 177: Israeli Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 178: Saudi Arabian Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 179: Tuberculosis Therapeutics Historic Market Analysis in Saudi Arabia in US$ Thousand by Disease Type: 2009-2017

TABLE 180: Saudi Arabian Tuberculosis Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 181: Saudi Arabian Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Therapy for the Period 2018-2025

TABLE 182: Tuberculosis Therapeutics Historic Market Analysis in Saudi Arabia in US$ Thousand by Therapy: 2009-2017

TABLE 183: Saudi Arabian Tuberculosis Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 184: Tuberculosis Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 185: United Arab Emirates Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017

TABLE 186: Tuberculosis Therapeutics Market Share Distribution in United Arab Emirates by Disease Type: 2009 VS 2019 VS 2025

TABLE 187: Tuberculosis Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025

TABLE 188: United Arab Emirates Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017

TABLE 189: Tuberculosis Therapeutics Market Share Distribution in United Arab Emirates by Therapy: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 190: Tuberculosis Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 191: Rest of Middle East Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017

TABLE 192: Rest of Middle East Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 193: Tuberculosis Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025

TABLE 194: Rest of Middle East Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017

TABLE 195: Rest of Middle East Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

AFRICA

TABLE 196: African Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Disease Type: 2018 to 2025

TABLE 197: Tuberculosis Therapeutics Market in Africa by Disease Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 198: African Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 199: African Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Therapy: 2018 to 2025

TABLE 200: Tuberculosis Therapeutics Market in Africa by Therapy: A Historic Review in US$ Thousand for 2009-2017

TABLE 201: African Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

ASTRAZENECA PLC

ELI LILLY AND COMPANY

GLAXOSMITHKLINE PLC

JOHNSON & JOHNSON

LUPIN LTD.

MERCK & CO., INC.

OTSUKA PHARMACEUTICAL CO., LTD.

PANACEA BIOTEC LTD.

PFIZER, INC

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Astrazeneca Plc
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Lupin Ltd.
  • Merck & Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Panacea Biotec Ltd.
  • Pfizer, Inc
Note: Product cover images may vary from those shown
Adroll
adroll